Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramedullary Calcium Sulfate Antibiotic Depot for Prevention of Open Fracture Related Infection
NCT05766670Phase 3Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Apr 2024
- Primary completion
- Jan 2027
- Modality
- Nanoparticles, Implantable Devices, Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of vancomycin, tobramycin in fracture-related infection (FRI), sponsored by Wake Forest University Health Sciences. Started Apr 2024; status: recruiting.
02
Drugs
vancomycintobramycin
03
Conditions
fracture-related infection (FRI)
Beyond the preview
Go deeper on NCT05766670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05766670.